Cargando…

Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas

The critical role of the Hippo pathway has been recently investigated in various cancers, but little is known about its role in glioblastoma (GBM). In order to evaluate the clinical relevance of the Hippo pathway in GBM, we generated a core gene expression signature from four different previously-es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eui Hyun, Sohn, Bo Hwa, Eun, Young-Gyu, Lee, Dong Jin, Yim, Sun Young, Kang, Seok-Gu, Lee, Ju-Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464204/ https://www.ncbi.nlm.nih.gov/pubmed/32717825 http://dx.doi.org/10.3390/cells9081761

Ejemplares similares

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
por: Eun, Young-Gyu, et al.
Publicado: (2017)

Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
por: Sohn, Bo Hwa, et al.
Publicado: (2018)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

A comprehensive evaluation of Hippo pathway silencing in sarcomas
por: Merritt, Nicole M., et al.
Publicado: (2018)

Hippo Pathway in Regulating Drug Resistance of Glioblastoma
por: Casati, Giacomo, et al.
Publicado: (2021)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
por: Huang, Boyuan, et al.
Publicado: (2023)

Clinically conserved genomic subtypes of gastric adenocarcinoma
por: Jeong, Yun Seong, et al.
Publicado: (2023)

Short-term Efficacy of Topical Immunosuppressive Agents on the Survival of Cultivated Allo-Conjunctival Equivalents
por: Shin, Young Joo, et al.
Publicado: (2008)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma
por: Son, Seung-Myoung, et al.
Publicado: (2019)

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2020)

Therapeutic Effect of IL-4 Receptor-Targeting Pro-Apoptotic Peptide (AP1-ELP-KLAK) in Glioblastoma Tumor Model
por: Sarangthem, Vijaya, et al.
Publicado: (2021)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Genomic Perspective on Mouse Liver Cancer Models
por: Yim, Sun Young, et al.
Publicado: (2019)

An Overview of the Genomic Characterization of Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2021)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020)

The long multi-epitope peptide vaccine combined with adjuvants improved the therapeutic effects in a glioblastoma mouse model
por: Tran, Thi-Anh-Thuy, et al.
Publicado: (2022)

Silencing GMPPB Inhibits the Proliferation and Invasion of GBM via Hippo/MMP3 Pathways
por: Huang, Zi-Lu, et al.
Publicado: (2023)

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
por: Park, Hun Ho, et al.
Publicado: (2021)

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
por: DeCordova, Syreeta, et al.
Publicado: (2020)

Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma
por: Molina, Maria L., et al.
Publicado: (2019)

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
por: Oh, Sejin, et al.
Publicado: (2020)

Extended Culture of Bone Marrow with Granulocyte Macrophage-Colony Stimulating Factor Generates Immunosuppressive Cells
por: Na, Hye Young, et al.
Publicado: (2018)

Emodin in Rheum undulatum inhibits oxidative stress in the liver via AMPK with Hippo/Yap signalling pathway
por: Lee, Eun Hye, et al.
Publicado: (2020)

Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity
por: Bakos, Orneala, et al.
Publicado: (2018)

Hippo Signaling in the Endometrium
por: Moon, Sohyeon, et al.
Publicado: (2022)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

Dishevelling Wnt and Hippo
por: Kim, Nam Hee, et al.
Publicado: (2018)

Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway
por: Zhu, Bowen, et al.
Publicado: (2020)

Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway
por: Hu, Dan, et al.
Publicado: (2022)

Inhibition of the interaction between Hippo/YAP and Akt signaling with ursolic acid and 3′3-diindolylmethane suppresses esophageal cancer tumorigenesis
por: Meng, Ruo Yu, et al.
Publicado: (2023)

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
por: Lee, Se Jeong, et al.
Publicado: (2015)

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
por: Hernández, Ainhoa, et al.
Publicado: (2021)

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

New Therapeutic Approach for Targeting Hippo Signalling Pathway
por: Dominguez-Berrocal, Leticia, et al.
Publicado: (2019)

Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia
por: Yeo, Min-Kyung, et al.
Publicado: (2018)

Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients
por: Kong, Byung Ho, et al.
Publicado: (2014)

Bazedoxifene enhances paclitaxel efficacy to suppress glioblastoma via altering Hippo/YAP pathway
por: Fu, Weiwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ud0rt34k7licr0ph946rk11l1e